Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (261-270 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|April 16, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
The American Journal of Cardiology|October 15, 1991
Thrombolytic therapy in patients requiring cardiopulmonary resuscitationA N Tenaglia, R M Califf, R J Candela, et al.
Journal of the American College of Cardiology|May 1, 1988
Comparison of time domain and frequency domain variables from the signal-averaged electrocardiogram: a multivariable analysisS J Worley, D B Mark, W M Smith, et al.
The American Journal of Cardiology|April 27, 2000
The benefit of abciximab in percutaneous coronary revascularization is not device-specificD L Bhatt, A M Lincoff, R M Califf, et al.
American Heart Journal|October 28, 1999
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experienceI C Gilchrist, L H Gardner, J B Muhlestein, et al.
The American Journal of Cardiology|June 1, 1984
"Left main equivalent" coronary artery disease: its clinical presentation and prognostic significance with nonsurgical therapyR M Califf, M J Conley, V S Behar, et al.
Circulation|February 18, 1997
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) GroupE J Topol, R M Califf, F Van de Werf, et al.
Journal of the American College of Cardiology|August 1, 1993
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot StudyN S Kleiman, E M Ohman, R M Califf, et al.
The American Journal of Cardiology|September 15, 1989
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)M A Hlatky, R E Boineau, M B Higginbotham, et al.
Annals of Surgery|October 1, 1984
Clinical characteristics and current management of medically refractory unstable anginaJ S Rankin, J R Newton, R M Califf, et al.
Pageof 57

Showing results (261-270 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|April 16, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
The American Journal of Cardiology|October 15, 1991
Thrombolytic therapy in patients requiring cardiopulmonary resuscitationA N Tenaglia, R M Califf, R J Candela, et al.
Journal of the American College of Cardiology|May 1, 1988
Comparison of time domain and frequency domain variables from the signal-averaged electrocardiogram: a multivariable analysisS J Worley, D B Mark, W M Smith, et al.
The American Journal of Cardiology|April 27, 2000
The benefit of abciximab in percutaneous coronary revascularization is not device-specificD L Bhatt, A M Lincoff, R M Califf, et al.
American Heart Journal|October 28, 1999
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experienceI C Gilchrist, L H Gardner, J B Muhlestein, et al.
The American Journal of Cardiology|June 1, 1984
"Left main equivalent" coronary artery disease: its clinical presentation and prognostic significance with nonsurgical therapyR M Califf, M J Conley, V S Behar, et al.
Circulation|February 18, 1997
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) GroupE J Topol, R M Califf, F Van de Werf, et al.
Journal of the American College of Cardiology|August 1, 1993
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot StudyN S Kleiman, E M Ohman, R M Califf, et al.
The American Journal of Cardiology|September 15, 1989
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)M A Hlatky, R E Boineau, M B Higginbotham, et al.
Annals of Surgery|October 1, 1984
Clinical characteristics and current management of medically refractory unstable anginaJ S Rankin, J R Newton, R M Califf, et al.
Pageof 57